Case Study
Removing duplication of assessments for Antenatal and Newborn (ANNB) screening laboratories

Overview

UKAS, the UK Accreditation body, has entered into an agreement with Public Health England to incorporate Antenatal and Newborn (ANNB) screening requirements into routine ISO 15189 assessment activities, thereby removing duplicate assessments. This benefits laboratories that provide testing for infectious diseases in pregnancy, sickle cell and thalassaemia, Down’s syndrome, Edwards’ syndrome, Patau’s syndrome and rare conditions identified from newborn blood spots, as they will no longer have to allocate time to be inspected by PHE.

Further information is available on the UKAS website.




Can you suggest a case study or research report to include on business benefits?